CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 50 enrolled
Drug / intervention
Test Product +3 moreother
Likely dose
Micellar cleanser 0.09 ml applied topicallyAI-extracted
Key inclusion· 5
  • ✓Age 18-65 years inclusive
  • ✓Fitzpatrick phototype I to IV
  • ✓Intact skin at the volar forearm with no baseline dryness or redness
  • ✓Free of clinically relevant dermatological conditions per dermatologist assessment
Key exclusion· 9
  • ✕History of significant dermatological diseases or conditions (e.g., atopic dermatitis, dermatographism)
  • ✕Active dermatosis (local or disseminated)
  • ✕Open sores, pimples, or cysts at the application site
  • ✕Immunocompromised status

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03119688
NCT03119688N/ACompleted
CompareCT.gov

A Clinical Study to Assess the Mildness of a Cosmetic Cleanser in Healthy Subjects Using the Forearm-Controlled Application Technique (FCAT)

GlaxoSmithKline·interventional·Posted Apr 18, 2017·Updated May 2, 2019

In Brief

A clinical study evaluating Test Product, Positive Control, and 2 other interventions for Skin Care. Completed, enrolled 50 participants across 2 sites.

Detailed Summary

The objective of this clinical study is to assess the relative mildness of a cosmetic facial cleanser in comparison to water through repeated application to the volar forearm using the FCAT wash procedure.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSkin Care
CountriesBrazil
Collaborators--

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedApr 18, 2017
Enrollment StartMay 8, 2017
Primary CompletionMay 26, 2017
TodayJul 2, 2026
Enrollment to primary: 18 daysPosted 9.2 years ago

Interventions

Test Productother

Micellar cleanser (0.09 ml)

Positive Controlother

Bar Soap (rubbed for 6 seconds to generate a lather)

Reference Productother

Sterile Water (0.09 ml)

No Treatmentother

Unwashed area of the forearm